{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7114,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "key_messages",
      "function": "quantify_opportunity",
      "notes": "The slide outlines the financial impact of Section 45X and state-level incentives on the Giga America project.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/11",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "key_messages",
      "function": "present_solution",
      "notes": "The slide uses a structured list format to present three core pillars of the decision.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/12",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart is a waterfall-bridge showing cash flow components.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/13",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "propose_solution",
      "function": "present_framework",
      "notes": "Uses a hub-and-spoke diagram to illustrate capital formation strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/14",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide outlines a multi-pronged capital strategy involving equity, debt, and government grants/incentives.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/15",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "Uses a comparison frame to illustrate why EV and ESS markets are decoupling.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/16",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-16",
      "loopMatches": [
        {
          "to": 17,
          "from": 16,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "00f2a553-2f8d-4c3f-a203-e0a0c8c3aa6f",
          "evidence": "The slides highlight the deep market short for ESS solutions",
          "position": 1,
          "objective": "What are the consequences of not acting in the ESS market?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "scenario_table",
      "function": "analyze_data",
      "notes": "The slide uses stacked bar charts to visualize regional supply/demand balances for LFP batteries.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/17",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-17",
      "loopMatches": [
        {
          "to": 17,
          "from": 16,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "00f2a553-2f8d-4c3f-a203-e0a0c8c3aa6f",
          "evidence": "The slides highlight the deep market short for ESS solutions",
          "position": 1,
          "objective": "What are the consequences of not acting in the ESS market?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/18",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-9893-749c-b533-06cd3418bb0a",
      "docSlug": "bb4f02bced849555a2b51bd698c445eb",
      "documentTitle": "Freyr | Results Presentation Deck | 19 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "closing_ask",
      "function": "transition",
      "notes": "The slide uses a high-quality photograph of a worker in a FREYR facility as a background.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-9893-749c-b533-06cd3418bb0a/19",
      "deckHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a",
      "deckAnchorHref": "/decks/019de075-9893-749c-b533-06cd3418bb0a#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 11,
          "beatId": "917aaaf0-b313-4e9e-b64a-b6f31fe31732",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "The final slides outline key takeaways and a call to action",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/2h8S9NBUCVFMAnXfdMH-JlPpZGoCjeoiu4HPI6BRbVA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yZjM1NTA5M2UwZDE2MTBmNmEwZGQ1NDRjNDkxNjBmNy9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/1",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/kXa72tQn3fLVfPPWqw7YVqEUvqL06tCr6eBta_ma5W8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yZjM1NTA5M2UwZDE2MTBmNmEwZGQ1NDRjNDkxNjBmNy9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/zgv5UqT6M6KmrlbsLo5g-v5IZZf97xBYOyNJhhMqzv0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yZjM1NTA5M2UwZDE2MTBmNmEwZGQ1NDRjNDkxNjBmNy9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/qbA7Jofjg20pRrvFVlmERz2cQe6uO7gX9wC8DJHjASw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yZjM1NTA5M2UwZDE2MTBmNmEwZGQ1NDRjNDkxNjBmNy9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/2",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "The slide uses a combination of bulleted benefits and a visual process diagram to explain Targeted Alpha Therapy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/3",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-3",
      "loopMatches": [
        {
          "to": 3,
          "from": 3,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "dd87dc04-cc08-4b30-b189-b282ebf2bca6",
          "evidence": "Radiopharmaceuticals are poised to become one of the primary pillars of modern cancer therapy",
          "position": 0,
          "objective": "Why now is the right time for radiopharmaceuticals in cancer therapy",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.8,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 3,
          "beatId": "008ad26e-c95b-48bd-9238-d1de537c7db4",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Radiopharmaceuticals are poised to become one of the primary pillars of modern cancer therapy",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": "The slide uses a process-oriented layout to highlight vertical integration.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/4",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "7bd31d45-b6db-4144-adc5-b4ee798fbef9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Fusion is Differentiated in the Emerging Radiopharmaceutical Space",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style visualization to represent clinical trial progress.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/5",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "7bd31d45-b6db-4144-adc5-b4ee798fbef9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Fusion is Differentiated in the Emerging Radiopharmaceutical Space",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": "The slide uses a two-column layout to contrast supply partnerships with internal manufacturing infrastructure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/6",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "7bd31d45-b6db-4144-adc5-b4ee798fbef9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Fusion is Differentiated in the Emerging Radiopharmaceutical Space",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "team_bio",
      "function": "other",
      "notes": "Includes a logo grid of past/affiliated companies at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/7",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 7,
          "from": 7,
          "beatId": "9a0be983-14b6-4a83-80ed-f4c29674fff7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "Fusion's Radiopharmaceutical & Oncology Drug Development Expertise",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/8",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a clinical imaging case study (A-D) showing patient response over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/9",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-9",
      "loopMatches": [
        {
          "to": 10,
          "from": 9,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "025171a9-8d84-47fd-8ab7-652a56c1e9fb",
          "evidence": "Multiple investigator sponsored studies support potential of 225Ac-PSMA",
          "position": 1,
          "objective": "Highlighting the potential of 225Ac-PSMA as a quick win and big bet",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 9,
          "beatId": "f986bb4f-9181-47b0-a7be-a48832a68309",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Size",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "Multiple investigator sponsored studies support potential of 225Ac-PSMA",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes specific clinical study citation (Zacherl et al. 2021).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/10",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-10",
      "loopMatches": [
        {
          "to": 10,
          "from": 9,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "025171a9-8d84-47fd-8ab7-652a56c1e9fb",
          "evidence": "Multiple investigator sponsored studies support potential of 225Ac-PSMA",
          "position": 1,
          "objective": "Highlighting the potential of 225Ac-PSMA as a quick win and big bet",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 9,
          "beatId": "f986bb4f-9181-47b0-a7be-a48832a68309",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Size",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "Multiple investigator sponsored studies support potential of 225Ac-PSMA",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Includes competitive benchmarking context in the footer notes regarding Endocyte and POINT clinical trial data sizes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/11",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 11,
          "beatId": "27d51353-4726-44b4-be84-702e743bbddb",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "FPI-2265 Development Strategy and FPI-2059 Development Program",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "product_demo",
      "function": "present_solution",
      "notes": "The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/12",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 11,
          "beatId": "27d51353-4726-44b4-be84-702e743bbddb",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "FPI-2265 Development Strategy and FPI-2059 Development Program",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a standard 3+3 dose escalation clinical trial design for a radiopharmaceutical.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/13",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 11,
          "beatId": "27d51353-4726-44b4-be84-702e743bbddb",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Product",
          "beatSlug": "sequoia-pitch-product",
          "evidence": "FPI-2265 Development Strategy and FPI-2059 Development Program",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/14",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a waterfall plot comparison to contrast clinical outcomes of two different therapeutic modalities.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/15",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify IGF-1R expression across different cancer types.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/16",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide uses a process flow diagram to map out different study arms (Single Ascending Dose, CASS, Multiple Dose Escalation, and Cold/Hot Dosing).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/17",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "FPI-1434 clinical data presentation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/18",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "other",
      "function": "cite_precedent",
      "notes": "The slide outlines two main pillars of the collaboration: targeted alpha therapies and combination therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/19",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a Y-shaped antibody diagram to illustrate bispecific binding.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/20",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-992f-724e-90ab-5f77d740e3ca",
      "docSlug": "2f355093e0d1610f6a0dd544c49160f7",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide highlights a 'vaccine effect' in 13/15 animals and mentions IP protection for these combinations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-992f-724e-90ab-5f77d740e3ca/21",
      "deckHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca",
      "deckAnchorHref": "/decks/019de075-992f-724e-90ab-5f77d740e3ca#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}